Mthfd2tm1c(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Mthfd2tm1c(EUCOMM)Wtsi |
| Name: |
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase; targeted mutation 1c, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:7427381 |
| Gene: |
Mthfd2 Location: Chr6:83282673-83302890 bp, - strand Genetic Position: Chr6, 35.94 cM
|
| Alliance: |
Mthfd2tm1c(EUCOMM)Wtsi page
|
| IMPC: |
Mthfd2 gene page |
|
| Mutant Cell Lines: |
EPD0752_2_A07, EPD0752_2_F07 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:324877
|
| Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Conditional ready, No functional change) |
| Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 83290107 of Chromosome 6 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 83290957. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele was created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:173534, J:324877)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Mthfd2 Mutation: |
23 strains or lines available
|
|
| Original: |
J:324877 Sugiura A, et al., MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function. Immunity. 2022 Jan 11;55(1):65-81.e9 |
| All: |
3 reference(s) |
|